Operating Lease, Right-of-Use Asset of Vir Biotechnology, Inc. from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vir Biotechnology, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Vir Biotechnology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $63,555,000, a 4.6% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Vir Biotechnology, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $63,555,000 +$2,776,000 +4.6% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $64,853,000 +$2,587,000 +4.2% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $58,559,000 -$11,787,000 -17% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $59,680,000 -$11,502,000 -16% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $60,779,000 -$11,843,000 -16% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $62,266,000 -$12,668,000 -17% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $70,346,000 -$11,159,000 -14% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $71,182,000 -$11,375,000 -14% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $72,622,000 -$12,094,000 -14% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $74,934,000 -$11,945,000 -14% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $81,505,000 -$6,826,000 -7.7% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $82,557,000 -$4,663,000 -5.3% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $84,716,000 +$27,150,000 +47% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $86,879,000 +$27,907,000 +47% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $88,331,000 +$27,870,000 +46% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $87,220,000 +$25,273,000 +41% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $57,566,000 +$42,804,000 +290% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $58,972,000 +$43,795,000 +289% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $60,461,000 +$44,454,000 +278% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $61,947,000 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $14,762,000 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $15,177,000 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 $16,007,000 31 Mar 2020 10-Q 12 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.